&nbsp;

May 2022

Drug

lenvatinib

Other Name(s): Lenvima®

Quick Link(s):

Sep 2023

Drug

lanreotide

Other Name(s): Somatuline® Autogel®

Quick Link(s):

Jun 2024

Drug

liposomal irinotecan

Other Name(s): Onivyde® (Baxalta Canada)

Quick Link(s):

Sep 2017

Regimen

LETR

Cancer Type:

Breast

Intent: Adjuvant

Funding:

ODB - General Benefit

letrozole

Drugs Used:

letrozole

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

LETR

Cancer Type:

Breast

Intent: Palliative

Funding:

ODB - General Benefit

letrozole

Drugs Used:

letrozole

Quick Link(s):

Regimen Monograph

Aug 2025

Regimen

LENA

Cancer Type:

Hematologic,

Myelodysplastic Syndrome (MDS)

Intent: Palliative

Funding:

ODB Limited Use

lenalidomide - For the treatment of patients with anemia due to myelodysplastic syndrome (MDS), according to clinical criteria

Drugs Used:

lenalidomide

Quick Link(s):

Regimen Monograph

May 2022

Regimen

LOMU

Cancer Type:

Central Nervous System

Intent: Palliative

Funding:

ODB - General Benefit

lomustine

Drugs Used:

lomustine

Quick Link(s):

Regimen Monograph

Aug 2024

Regimen

OCTR

Cancer Type:

Gastrointestinal,

Neuroendocrine (GI),

Lung,

Neuroendocrine (Lung)

Intent: Palliative

Funding:

ODB - General Benefit

octreotide

Drugs Used:

octreotide

Quick Link(s):

Regimen Monograph

Jun 2024

Regimen

OXALRALT

Cancer Type:

Gastrointestinal,

Colorectal,

Esophagus,

Gastric / Stomach,

Small bowel and appendix

Intent: Adjuvant, Palliative

Funding:

New Drug Funding Program

Raltitrexed - Metastatic Colorectal Small Bowel or Appendiceal Cancer

New Drug Funding Program

Raltitrexed - Metastatic Esophageal, Gastroesophageal Junction, or Gastric Cancer

New Drug Funding Program

Raltitrexed - Adjuvant Colorectal, Small Bowel, or Appendiceal Cancer

New Drug Funding Program

Raltitrexed - Adjuvant Esophageal, Gastroesophageal Junction, or Gastric Cancer

Drugs Used:

raltitrexed,

oxaliplatin

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

LENA

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB Limited Use

lenalidomide - For the maintenance treatment of patients with newly diagnosed multiple myeloma, following ASCT, according to clinical criteria

Drugs Used:

lenalidomide

Quick Link(s):

Regimen Monograph

May 2022

Regimen

LETR

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Funding:

ODB - General Benefit

letrozole

Drugs Used:

letrozole